Nautilus Biotechnology

Nautilus Biotechnology is a development-stage life sciences company building a single-molecule proteome analysis platform called Voyager™...

Facts

HQ: Seattle
Sectors: Biotechnology Research
Founded: 2016
Employees: 150
Stage: Public
Total raised: $200M SEC Form D filings Total of this company's SEC Form D filings
Last round: $200M · Jun 2021 SEC Form D
Founders: Sujal Patel, Parag Mallick, PhD

Signed a material agreement Sep 11, 2026 SEC Form 8-K
Leadership or executive-pay change Feb 27, 2025 SEC Form 8-K
Leadership or executive-pay change Jan 31, 2025 SEC Form 8-K
Signed a material agreement Feb 28, 2024 SEC Form 8-K
Leadership or executive-pay change Mar 31, 2022 SEC Form 8-K
Completed an acquisition or disposition Jun 10, 2021 SEC Form 8-K
Leadership or executive-pay change Jun 10, 2021 SEC Form 8-K
Raised $200M Jun 9, 2021 SEC Form D
Signed a material agreement Feb 8, 2021 SEC Form 8-K
Signed a material agreement Aug 12, 2020 SEC Form 8-K

People

Sujal Patel Executive, Co-founder and CEO, Executive Officer, Director

Online